News

PRX-07034 is a highly selective 5-HT6 receptor antagonist being developed for the treatment of obesity, as well as for cognitive impairment associated with Alzheimer's disease and schizophrenia. “We

The lung disease known as idiopathic pulmonary fibrosis (IPF), causes inflammation and scarring (fibrosis) in the lungs which hinders a person's ability to process oxygen often causing shortness

Developed by BioNumerik, Tavocept is a chemotherapeutic agent with uses in oncology and other disease indications. The initial development focus for Tavocept was to prevent peripheral nerve damage,

The study is being conducted by researchers at Johns Hopkins University. Mitomycin-C is a member of an important class of DNA damaging agents used to treat cancer. The

The study will include a total of 36 patients with advanced squamous cell carcinoma of the head and neck. The objective of the study is to investigate the

The vaccine is administered using Inovio Biomedical’s technology called the MedPulser gene delivery system. The research showed that in comparison with the gene gun delivery the MedPulser gene

The original decision to uphold the patent was on August 2 and specifically deals with the active ingredient in Lipitor called atorvastatin. Pfizer’s paatent is due to expire

Novartis had submitted an application in February for the extension of the marketing authorization to include the treatment of the rare disease mastocytosis. Mastocytosis is a disease in

Noxafil is an antifungal agent discovered and developed by Schering-Plough Research Institute to treat this fungal infection also known as oropharyngeal candidiasis (OPC). This follows the FDA approval